| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | -12,3 k € | -105.5% | 222,7 k € | -22.6% | 287,9 k € | +182.4% | 101,9 k € | -79.4% | 495,8 k € | -23.1% | 644,5 k € | +136.9% | 272,1 k € | -17.0% | 327,9 k € | +163.3% | 124,5 k € | -30.2% | 178,5 k € | +374.4% | 37,6 k € | +24.8% | 30,1 k € | -85.7% | 211,3 k € | +23.8% | 170,6 k € | +18.5% | 144,0 k € | +202.2% | -140,9 k € | +65.8% | -412,5 k € | |
| EBITDA | -15,7 k € | -107.6% | 205,7 k € | -12.1% | 233,8 k € | +267.4% | 63,6 k € | -84.9% | 421,7 k € | -21.1% | 534,2 k € | +172.9% | 195,7 k € | -23.4% | 255,6 k € | +221.2% | 79,6 k € | -39.9% | 132,4 k € | +341.8% | 30,0 k € | +259.0% | 8,4 k € | -54.3% | 18,3 k € | +114.6% | -125,3 k € | -686.6% | -15,9 k € | +92.4% | -210,6 k € | +49.5% | -416,8 k € | |
| Operating profit | -16,1 k € | -159.0% | 27,2 k € | -51.1% | 55,7 k € | +148.5% | -114,8 k € | -147.8% | 240,2 k € | -27.4% | 331,0 k € | +92.2% | 172,2 k € | +31.1% | 131,4 k € | +214.4% | 41,8 k € | -56.7% | 96,4 k € | +725.3% | 11,7 k € | +137.8% | -30,9 k € | -546.7% | 6,9 k € | +104.8% | -142,9 k € | -296.4% | -36,1 k € | +84.4% | -231,4 k € | +45.1% | -421,3 k € | |
| Profit/loss | -16,2 k € | -296.5% | 8,3 k € | -78.8% | 39,1 k € | +130.7% | -127,1 k € | -156.2% | 226,1 k € | -29.5% | 320,6 k € | +112.6% | 150,8 k € | +35.3% | 111,4 k € | +253.9% | 31,5 k € | -65.1% | 90,2 k € | +1211.5% | -8,1 k € | +77.1% | -35,5 k € | -871.4% | -3,7 k € | +97.3% | -137,7 k € | -143.7% | -56,5 k € | +77.0% | -245,7 k € | +44.8% | -445,0 k € | |
| Equity | -79,0 k € | -25.9% | -62,7 k € | +11.7% | -71,0 k € | +35.5% | -110,0 k € | -744.6% | 17,1 k € | +108.2% | -209,0 k € | +60.5% | -529,6 k € | +22.2% | -680,4 k € | +14.1% | -791,8 k € | +3.8% | -823,3 k € | +9.9% | -913,5 k € | -0.9% | -905,4 k € | -4.1% | -869,9 k € | -0.4% | -866,3 k € | -17.9% | -734,8 k € | -8.3% | -678,3 k € | -56.8% | -432,6 k € | |
| Total assets | 516,0 k € | -23.5% | 674,5 k € | -20.6% | 849,0 k € | +10.5% | 768,5 k € | -27.4% | 1,1 M € | -9.6% | 1,2 M € | +259.6% | 325,9 k € | +181.4% | 115,8 k € | -43.1% | 203,6 k € | -34.5% | 310,7 k € | +68.1% | 184,9 k € | -30.0% | 264,3 k € | +110.6% | 125,5 k € | -31.1% | 182,1 k € | -14.5% | 213,0 k € | -19.8% | 265,4 k € | +25.2% | 212,0 k € | |
| Cash | 1,3 k € | -60.2% | 3,2 k € | +59.6% | 2,0 k € | -95.9% | 49,7 k € | +615.0% | 7,0 k € | -71.3% | 24,2 k € | +130.2% | 10,5 k € | +1.0% | 10,4 k € | +56.4% | 6,7 k € | -81.3% | 35,6 k € | +155.8% | 13,9 k € | +239.5% | 4,1 k € | +6482.3% | 62,2 € | -99.6% | 16,3 k € | +358.1% | 3,6 k € | -67.3% | 10,9 k € | — | ||
| Debts | 595,0 k € | -19.3% | 737,2 k € | -19.9% | 920,0 k € | +4.8% | 878,2 k € | -15.7% | 1,0 M € | -24.2% | 1,4 M € | +61.9% | 849,3 k € | +7.2% | 792,0 k € | -20.3% | 993,8 k € | -11.0% | 1,1 M € | +2.3% | 1,1 M € | -5.9% | 1,2 M € | +16.5% | 995,4 k € | -5.1% | 1,0 M € | +10.6% | 947,7 k € | +0.4% | 943,7 k € | +46.4% | 644,7 k € | |
| Staff | — | — | — | 1,3 | 2 | 3 | 2,9 | 2,1 | 1,1 | 1,1 | 1,7 | 0,1 | 5,7 | 9,6 | 5,1 | 1,9 | — | |||||||||||||||||
Private limited company · Gembloux · incorporated on 30/05/2007
Private limited company loss-making in the latest fiscal year. Cash position declining (-60.2%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
SOURANIS EUROPE is a Private limited company incorporated in 2007. Its main activity is: Other human health activities. Its registered office is in Gembloux.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette